rs1176314146
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 2P and 7B. PM2BP4_StrongBP6_ModerateBP7
The NM_015909.4(NBAS):c.7098A>G(p.Ala2366Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000209 in 1,438,372 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000021 ( 0 hom. )
Consequence
NBAS
NM_015909.4 synonymous
NM_015909.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.84
Publications
0 publications found
Genes affected
NBAS (HGNC:15625): (NBAS subunit of NRZ tethering complex) This gene encodes a protein with two leucine zipper domains, a ribosomal protein S14 signature domain and a Sec39 like domain. The protein is thought to be involved in Golgi-to-ER transport. Mutations in this gene are associated with short stature, optic nerve atrophy, and Pelger-Huet anomaly. [provided by RefSeq, Oct 2012]
NBAS Gene-Disease associations (from GenCC):
- infantile liver failure syndrome 2Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
- short stature-optic atrophy-Pelger-Huët anomaly syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Illumina, Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (REVEL=0.009).
BP6
Variant 2-15167066-T-C is Benign according to our data. Variant chr2-15167066-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 2755375.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-1.84 with no splicing effect.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD2 exomes AF: 0.00000845 AC: 2AN: 236704 AF XY: 0.0000157 show subpopulations
GnomAD2 exomes
AF:
AC:
2
AN:
236704
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000209 AC: 3AN: 1438372Hom.: 0 Cov.: 31 AF XY: 0.00000421 AC XY: 3AN XY: 712110 show subpopulations
GnomAD4 exome
AF:
AC:
3
AN:
1438372
Hom.:
Cov.:
31
AF XY:
AC XY:
3
AN XY:
712110
show subpopulations
African (AFR)
AF:
AC:
0
AN:
33092
American (AMR)
AF:
AC:
0
AN:
43426
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
24468
East Asian (EAS)
AF:
AC:
0
AN:
39388
South Asian (SAS)
AF:
AC:
2
AN:
82454
European-Finnish (FIN)
AF:
AC:
0
AN:
52500
Middle Eastern (MID)
AF:
AC:
0
AN:
5638
European-Non Finnish (NFE)
AF:
AC:
1
AN:
1098078
Other (OTH)
AF:
AC:
0
AN:
59328
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Apr 05, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.